Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
2.
Eur J Gynaecol Oncol ; 35(2): 134-9, 2014.
Article in English | MEDLINE | ID: mdl-24772914

ABSTRACT

AIM: The purpose of this study was to evaluate the maspin expression in endometrial hyperplasia and cancer, and also to investigate its relation with angiogenesis. MATERIALS AND METHODS: A total of 19 women with complex atypical hyperplasia, 44 patients with simple hyperplasia without atypia, and 67 patients with endometrial carcinoma were included. Maspin expression was assessed by immunohistochemistry (IHC), and tested for possible significant relation with age, FIGO stage, histologic type, grade, depth of myometrial invasion (MI), lymphovascular space involvement (LVSI), lymph node metastasis, and overall survival (OS). Angiogenesis was determined by vascular endothelial growth factor (VEGF) staining. RESULTS: Maspin expression was detected in only three patients with endometrial hyperplasia (5%). In patients with endometrial cancer, cytoplasmic and nuclear maspin expressions were detected in 36 (53.7%) and 18 (26.9%) patients, respectively. No significant relation was noted between staining localizations and prognostic variables. The five-year OS rate for patients with cytoplasmic staining was 91%, compared to 87% for patients without staining (p = 0.31). These values for nuclear expression were 100% and 87%, respectively (p = 0.16). The cytoplasmic and nuclear maspin expressions were found to be significantly correlated with VEGF (r = 0.278, p = 0.02 and r = 0.295, p = 0.01, respectively). DISCUSSION: This is the first study to demonstrate the relation between maspin expression and angiogenesis in endometrial cancer. Although no survival difference was noted for cytoplasmic or nuclear maspin expressions, a tendency was detected for nuclear staining. Further series will clarify the exact prognostic role of maspin expression in gynecological malignancies including endometrial cancer.


Subject(s)
Carcinoma, Endometrioid/metabolism , Endometrial Hyperplasia/metabolism , Endometrial Neoplasms/metabolism , Neovascularization, Pathologic/metabolism , Serpins/metabolism , Adult , Aged , Female , Humans , Immunohistochemistry , Middle Aged , Vascular Endothelial Growth Factor A/metabolism
3.
Acta Anaesthesiol Belg ; 60(3): 189-90, 2009.
Article in English | MEDLINE | ID: mdl-19961118

ABSTRACT

Intracranial venous thrombosis is rarely seen prior to delivery. We present our anesthetic management of a term parturient with an acute onset severe superior sagittal sinus thrombosis urgently referred to us. General anesthesia was performed in order to avoid potential increased risk of morbidity after spinal anesthesia in this particular parturient.


Subject(s)
Anesthesia, General , Anesthesia, Obstetrical , Cesarean Section , Sagittal Sinus Thrombosis/complications , Acute Disease , Adult , Female , Humans , Infant, Newborn , Pregnancy
4.
Int J Gynecol Cancer ; 18(2): 235-40, 2008.
Article in English | MEDLINE | ID: mdl-17587313

ABSTRACT

The purpose of this study was to evaluate the accuracy of frozen section diagnosis in patients who were subjected to the exploratory laparotomy for pelvic mass. Overall, 207 patients were included in this study and the mean age of the patients was 50.9 +/- 14.9 years (range, 18-84 years). Of these patients, 98 (47%) had benign, 16 (8%) had borderline, and 93 (45%) had malignant histologies at permanent section. The diagnosis at frozen section was deferred for three patients (1.4%) and these patients were excluded from the further analyses. The overall discordance rate was 5.3%. To calculate the sensitivity and specificity values, 2 x 2 contingency tables were constructed in two ways. In the first calculation, borderline histology was considered malignant, and the sensitivity and specificity rates were 97% and 92%, respectively. In the second analysis, it was accepted as benign, and these values were 100% and 98%, respectively. To determine the possible factors related with discordant diagnoses, age, menopausal status, tumoral size, laterality of tumors, and histologic diagnoses were analyzed. Significant association was noted for size and borderline and mucinous histologies. In patients with borderline histology, the discordance rate was 40%. This value for the remaining patients was 3.2% (P < 0.001). The rate of misdiagnosis was 17.4% for mucinous tumors, whereas it was 4.8% for the remaining epithelial tumors (P = 0.03). Frozen section evaluation revealed high sensitivity and specificity values in this study. To increase the accuracy of diagnosis, further diagnostic markers are needed especially for patients with large lesions, borderline tumors, and mucinous histologies.


Subject(s)
Frozen Sections , Ovarian Neoplasms/pathology , Pelvic Neoplasms/pathology , Adnexal Diseases/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Middle Aged
5.
Int J Gynecol Cancer ; 16(5): 1789-93, 2006.
Article in English | MEDLINE | ID: mdl-17009973

ABSTRACT

Intratumoral angiogenesis has become an important issue after the identification of antiangiogenic therapeutics. The purpose of this study was to investigate the prognostic value of CD105 in patients with ovarian cancer and also to compare with CD31. Fifty-eight patients were included to this study. All the paraffin blocks were reviewed, and angiogenesis was determined by immunohistochemical staining, using anti-CD105 and anti-CD31 monoclonal antibodies. The mean microvessel density (MVD) with CD105 and CD31 were 28.78 +/- 22.20 and 28.69 +/- 18.57, respectively (P = 0.97). With respect to prognostic factors, CD31 was only significant for suboptimal cytoreduction (P = 0.02), and CD105 was significant for both advanced stage and suboptimal cytoreduction (P = 0.02 and P = 0.05, respectively). For survival analysis, patients were divided into three groups by quartiles for each marker (group 1, <25%; group 2, 25-75%; and group 3, >75%). By CD31, only significant difference was noted between group 1 and group 2 (P = 0.03). In analysis with CD105, the survival rate of patients with group 3 was significantly worse than group 1 and group 2 (P = 0.01 for both). In multivariate analysis, cytoreduction and MVD determined by CD105 remained significant. In this study, endoglin was found to be an independent predictor of poor survival. Therefore, it could be used for antiangiogenic therapies.


Subject(s)
Antigens, CD/metabolism , Biomarkers, Tumor/metabolism , Carcinoma/metabolism , Ovarian Neoplasms/metabolism , Receptors, Cell Surface/metabolism , Adult , Aged , Aged, 80 and over , Carcinoma/diagnosis , Endoglin , Female , Gene Expression Regulation, Neoplastic , Humans , Middle Aged , Neovascularization, Pathologic/metabolism , Ovarian Neoplasms/diagnosis , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Prognosis
6.
Placenta ; 27(2-3): 327-32, 2006.
Article in English | MEDLINE | ID: mdl-16338477

ABSTRACT

The aim of this study was to measure oxidant/antioxidant status in maternal and cord plasma and in placental tissue in gestational diabetes and to correlate the results with the quality of glycemic control of the mother. To achieve this, blood and placental tissue samples have been obtained from pregnant women with gestational diabetes mellitus (GDM) and from the umbilical cord of their fetuses. The same samples have been collected from pregnant women without GDM. In all the samples, oxidant and antioxidant parameters have been studied. It has been observed that the antioxidant defense system was impaired; xanthine oxidase, which is the main free radical-producing enzyme (XO) in the living cells, was activated; and oxidation reactions were accelerated in the samples obtained from patients with GDM. Results suggest presence of oxidant stress in the gestational diabetes, the reason probably being impaired antioxidant defense mechanism and increased free radical production through XO activation.


Subject(s)
Diabetes, Gestational/metabolism , Fetal Blood/metabolism , Oxidative Stress , Placenta/metabolism , Xanthine Oxidase/metabolism , Adult , Enzyme Activation , Female , Fetal Blood/chemistry , Free Radicals/analysis , Free Radicals/blood , Glutathione Peroxidase/metabolism , Humans , Oxidants/analysis , Oxidants/blood , Placenta/chemistry , Pregnancy , Superoxide Dismutase/metabolism
7.
Colorectal Dis ; 7(3): 228-31, 2005 May.
Article in English | MEDLINE | ID: mdl-15859959

ABSTRACT

OBJECTIVE: This study was conducted to determine the indications for and outcome of colorectal intervention in patients with advanced gynaecological malignancy. METHODS: Between January 1999 and June 2004, 27 gynaecological cancer patients underwent 36 colorectal intervention performed by general surgeons. The 36 operations were associated with 14 (39%) primary surgical procedures, 9 (25%) second-look laparotomies, and 13 (36%) procedures for recurrence or palliation. RESULTS: The mean age was 56 years (range 32-83 years). The majority of operations were performed in patients with ovarian (67%), endometrial (18%) and cervical (15%) malignancy. The primary indications for colorectal resection was tumour cytoreduction in 56% of the 36 operations. Other indications included repair of iatrogenic bowel injuries (n = 9, 25%), resection for multiple iatrogenic enterotomies (n = 4, 11%), and bowel obstruction (n = 3, 8%). The most frequently performed bowel operation was rectosigmoid resection with end-to-end anastomosis (n = 19, 53%). Colostomy was performed in 14% of the rectosigmoid resections at primary surgery. Small-bowel resection was required in 31% of the 36 operations. Postoperative complications included wound complications (14%), pulmonary infections (8%), cardiac complications (6%) and intra-abdominal abscess (6%). There was a single surgical mortality (3%). CONCLUSION: Colorectal intervention is frequently indicated during operations for advanced gynaecological malignancy, and they are associated with a significant rate of postoperative complications. Specialists operating on gynaecological malignancy should have the technical skills necessary to perform these procedures.


Subject(s)
Colectomy/methods , Colon, Sigmoid/surgery , Colostomy/methods , Genital Neoplasms, Female/surgery , Ileostomy/methods , Rectum/surgery , Adult , Aged , Aged, 80 and over , Anastomosis, Surgical , Colorectal Neoplasms/prevention & control , Colorectal Neoplasms/secondary , Female , Follow-Up Studies , Genital Neoplasms, Female/pathology , Humans , Incidence , Middle Aged , Postoperative Complications/epidemiology , Retrospective Studies , Treatment Outcome
8.
Int J Gynaecol Obstet ; 55(2): 117-21, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8960991

ABSTRACT

OBJECTIVE: To determine the incidence and types of congenital anomalies in a Turkish population. METHOD: The total number of neonates (9160) born in the Department of Obstetrics and Gynecology, Gazi University Faculty of Medicine during 1988-1995 were studied retrospectively. Newborns with congenital anomaly were identified from their birth registries. The total incidence, types and combined anomalies were determined. Also, the relationship between congenital anomalies and maternal age and/or gender were investigated. For statistical evaluation, Chi-square test, Yates correction and Fisher's exact tests were used where appropriate. RESULTS: The overall congenital anomaly incidence was 1.11% and the NTD incidence was 0.27% in our population. Anencephaly was the second most common NTDs with the ratio of 40%, following the spina bifida cases. There was a significant difference between female and male newborns with ancephalocele (P < 0.05). Urogenital system anomalies were found to be the second most common type of malformation with an incidence of 0.21%. Facial and musculoskeletal system abnormalities were the third and fourth most common malformations. Omphalocele incidence in our population was 5 in 9160 births and gastrochisis was 1 in 9160 births. CONCLUSION: The overall congenital anomaly incidence in newborns in our population is 1.11%. The most common malformations were CNS and urogenital abnormalities. NTDs incidence was 0.27% in a Turkish population.


Subject(s)
Congenital Abnormalities/epidemiology , Age Factors , Anencephaly/epidemiology , Female , Humans , Incidence , Infant, Newborn , Male , Maternal Age , Retrospective Studies , Sex Factors , Spinal Dysraphism/epidemiology , Turkey/epidemiology , Urogenital Abnormalities
SELECTION OF CITATIONS
SEARCH DETAIL
...